The fly-in will focus on ways community pharmacies can serve their constituents and what changes to the payment model are needed to best care for them in the future.
The proposed Abatacept biosimilar is a dual biologic intended to suppress neuroinflammation via multiple immunomodulatory pathways, for the treatment of neurodegenerative conditions.
Generic Aubagio treats relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease, in adults.
